AUG 22, 2020 9:21 AM PDT

Could a Drug for Bipolar Disorder Treat COVID-19?

WRITTEN BY: Annie Lennon

Researchers have found that a drug currently used to treat bipolar disorder and hearing loss may also treat COVID-19 thanks to itsantibacterial and anti-inflammatory properties. 

Known as Ebselen, the new findings come after previous research showing it is able to block enzymes known as ‘Mpro’ that are necessary for the coronavirus to replicate in healthy cells. 

For the most recent study, researchers from the University of Chicago created computer models to understand how the drug and Mpro interact. In the end, they found that Ebelsen is able to bind to two different sites on the enzyme- both key for its function and ability to replicate. 

These findings suggest that Ebelsen may be a good drug candidate to treat COVID-19- especially as it is already in use, demonstrating its safety. The researchers also say that the drug highlights another vulnerability of the coronavirus that scientists may want to continue to investigate as the search for other drug candidates persist. 

Although promising results, however, the researchers also say that a lot more research is needed before they can properly determine how effective the drug may be at treating COVID-19. While computer models show it may be effective, real-life trials outside of the lab are needed to confirm its effectiveness. 

As such, while research may advance on this drug candidate, the researchers plan to focus their research on finding ore of SARS-CoV-2’s weak spots. 

“The main protease is one of many proteins in the virus that could be targeted with existing, repurposed drugs, and there are thousands of compounds to be considered,” says Professor Juan de Pablo, one of the study’s authors. 

“We are systematically investigating each of the proteins involved in the virus function and investigating their vulnerabilities and their responses to a wide range of drugs.”

 

Sources: Science AdvancesMedical News Today

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
NOV 22, 2020
Cannabis Sciences
Public Believes CBD is Cure-All Despite Lack of Evidence
NOV 22, 2020
Public Believes CBD is Cure-All Despite Lack of Evidence
Many people think that cannabidiol (CBD), a non-psychoactive compound in cannabis, can reduce symptoms from various cond ...
DEC 17, 2020
Genetics & Genomics
Using Tomatoes to Produce a Parkinson's Drug
DEC 17, 2020
Using Tomatoes to Produce a Parkinson's Drug
More and more people are being diagnosed with Parkinson's disease as the world's population ages. Scientists have now en ...
DEC 30, 2020
Drug Discovery & Development
Gene Therapy Cures Mice of Deafness
DEC 30, 2020
Gene Therapy Cures Mice of Deafness
Currently, around half a billion people suffer from hearing loss around the world. In about half of these cases, genetic ...
Loading Comments...